Elective induction of labour. A randomised prospective trial

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Clinical Trials

Background:

• Elective induction of labor is a common obstetric intervention.
• Optimal timing for labor induction in term pregnancies remains a subject of research.
• Potential benefits and risks of induction at 39-40 weeks require further investigation.

Purpose of the Study:

• To compare outcomes of elective labor induction at 39-40 weeks versus expectant management until 41 weeks in low-risk pregnancies.
• To assess the impact of elective induction on labor complications, maternal blood loss, and fetal well-being.
• To evaluate the safety and feasibility of elective induction for convenience.

Main Methods:

• Prospective, randomized trial comparing elective induction (39-40 weeks) with expectant management (until 41 weeks).
• Study included 111 women in the induction group and 117 controls.
• Outcomes measured included meconium staining, postpartum hemorrhage, labor duration, analgesia use, Apgar scores, and cesarean section rates.

Main Results:

• Elective induction significantly reduced meconium staining and postpartum blood loss compared to controls.
• No significant differences were observed in labor duration, pethidine use, or 1-minute Apgar scores.
• Cesarean section rates were lower, and epidural analgesia use was higher in the induced group, though not statistically significant.

Conclusions:

• Elective induction of labor at 39-40 weeks in low-risk pregnancies is associated with improved outcomes, including reduced meconium staining and blood loss.
• The procedure does not appear to increase risks to mother or child and may potentially reduce perinatal mortality from stillbirths.
• Delivery timing was similar, suggesting minimal impact on staff convenience, and the safety profile supports its consideration.